🥳

Congratulations to WCM Englander Institute for Precision Medicine's Director of Research Pathology Dr. Juan Miguel Mosquera, a Member of the Weill Cornell Medicine Pathology team, on his USCAP-accepted abstract with #EIPM's Dr. Majd Al Assad and colleagues, with Isabl Inc.. #PrecisionMedicine #pathology

Congrats to our colleague Dr. Majd Al Assaad (Majd Al Assaad, MD) on a great presentation of his research with @JyothiManohar23, Michael Sigouros, Drs. David Wilkes, Andrea Sboner, PhD @[email protected], Olivier Elemento, David J. Pisapia, and Juan Miguel Mosquera; with Isabl Inc. Weill Cornell Medicine Pathology USCAP #USCAP2022

Could an experimental approach to genetic testing in children and young adults with cancer match them with better treatment options? Drs. Andrew Kung and Elli Papaemmanuil, PhD, whose findings published in nature, think so. bit.ly/3Mu7I1i

Impressive turnaround times for cancer whole genome & transcriptome sequencing (cWGTS) - 9 days from start to finish - and application to pediatric & #AYAcancer From Elli Papaemmanuil, PhD and colleagues nature.com/articles/s4146…

Isabl's rapid whole-genome analysis opens the playbook for cancer treatment tcrn.ch/3Mr9AI9 | by Devin Coldewey

Congrats Elli Papaemmanuil, PhD, @jsmedmar, Andrew, and team Isabl Inc. on the new milestone! The FDA grants Isabl (YC W20) Breakthrough Device designation to improve the diagnosis of pediatric cancer patients: techcrunch.com/2022/05/18/isa…

Very happy to see this kind of technology coming to market for kids with cancer techcrunch.com/2022/05/18/isa…

MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing. The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community. ow.ly/Bt89103FVCW

Ultima Genomics claims $100 full genome sequencing after stealth $600M raise tcrn.ch/3x35WyY | by Devin Coldewey

What is the risk conferred by my disease? One of the hardest questions to answer in medicine. A on the development of the International Prognostic Scoring System Molecular in MDS published today bit.ly/3aNEU64

#NovaseqX is here to produce 20,000 human WGS per year. Promise of increased accuracy + #dragen integration. List price $200 per genome. The time for bringing comprehensive clinical grade whole genome sequencing to patients is NOW. Illumina isabl.io #IGF